Literature DB >> 6371459

Review of tumor markers for ovarian cancer.

G Umbach.   

Abstract

Forty-two substances having been described as potential tumor markers for ovarian cancer are reviewed regarding sensitivity, specificity, and correlation with clinical course of disease. At present, there is no reliable marker for the primary diagnosis of the vast majority of ovarian cancers. Tumor markers may however serve as adjunctive tools in monitoring ovarian cancer patients after treatment.

Entities:  

Mesh:

Year:  1984        PMID: 6371459     DOI: 10.1016/0306-9877(84)90166-x

Source DB:  PubMed          Journal:  Med Hypotheses        ISSN: 0306-9877            Impact factor:   1.538


  2 in total

1.  Practical applications of a monoclonal antibody (NDOG2) against placental alkaline phosphatase in ovarian cancer.

Authors:  J O Davies; E R Davies; K Howe; P Jackson; E Pitcher; B Randle; C Sadowski; G M Stirrat; C A Sunderland
Journal:  J R Soc Med       Date:  1985-11       Impact factor: 5.344

2.  14C1, an antigen associated with human ovarian cancer, defined using a human IgG monoclonal antibody.

Authors:  G Gallagher; F al-Azzawi; L P Walsh; G Wilson
Journal:  Clin Exp Immunol       Date:  1991-01       Impact factor: 4.330

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.